Apoptosis and cell growth inhibition as antitumor effector functions of interferons

Medical Oncology

Volumn 18, Issue 1, 2001, Pages 3-14

  Sangfelt, O ^a   Strander, H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apoptosis; Cell cycle arrest; Interferons; Resistance; Tumor cells

Indexed keywords

INTERFERON;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER RESISTANCE; CELL GROWTH; CELL PROLIFERATION; DRUG MECHANISM; GROWTH INHIBITION; MITOSIS INHIBITION; PRIORITY JOURNAL; REVIEW; TUMOR CELL;

APOPTOSIS; CELL CYCLE; CELL DIVISION; DRUG RESISTANCE, NEOPLASM; HUMANS; INTERFERONS; NEOPLASMS;

EID: 0034812551     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:18:1:3     Document Type: Review

References (95)

1. STATs: Signal transducers and activators of transcription
2. Production of interferon by human leukocytes in vitro
3. Interferon treatments of human malignancies - A short review
4. Interferon-induced enhancement of 2′,5′ oligoadenylate synthetase in mid-gut carcinoid tumors
5. Mechanism of the antitumor effect of interferon in mice
6. Interaction of IFNα/β with host cells essential to the early inhibition of Friend erythroleukemia visceral metastases in mice
7. Interferon and natural killer cell activity in multiple myeloma. Lack of correlation between interferon-induced enhancement of natural killer cell activity and clinical response to human interferon-α
8. Tumour-infiltrating lymphocytes in malignant melanoma and response to interferon alpha treatment
9. How do mutated oncogenes and tumor suppressor genes cause cancer?
10. Cell-cycle arrest versus cell death in cancer therapy
11. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
12. Caspase-dependent and -independent death pathways in cancer therapy
13. Mitochondria and cell death
14. Caspases: Killer proteases
15. Apoptosis and cacinogenesis
16. Cytolytic activity of interferon-gamma and its synergism with 5-fluorouracil
17. Induction of apoptosis and inhibition of cell growth are independent responses to IFN-α
18. Cytotoxic effect of interferon on primary tumor cells. Studies in various malignancies
19. Induction of apoptotic cell death in non-meanoma skin cancer by interferon-alpha
20. Identificaion of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the γ interferon-induced cell death
21. Interferon-α up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo
22. Effects of interferon-α on human B-cells: Repression of apoptosis and prevention of cell growth are independent responses of Burkitt lymphoma cell lines
23. Interferon-alpha protects myeloma cell lines from dexamethosone-induced apoptosis
24. Wild-type p53-induced apoptosis in a Burkitt lymphoma cell line is inhibited by interferon-γ
25. The effect of alpha and gamma-interferon on proliferation and production of IgE and beta 2-microglobulin in the human myeloma cell line U-266 and in an alpha-interferon resistant U-266 subline
26. Interferons as regulators of cell growth and differentiation
27. Evasion of apoptosis by DNA viruses
28. Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L
29. A study of the interferon antiviral mechanism: Apoptosis activation by the 2-5A system
30. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis
31. The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases
32. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitoge-activated T-lymphocytes
33. Defective TNF-α-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases
34. Apoptosis by death factor
35. Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-α in chronic myelogenous leukemia
36. Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon γ to produce erythroid cell apoptosis
37. Fas/APO-1 (CD95)-mediated apoptosis is activated by interferon-gamma and interferon-alpha in interleukin 6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines
38. Interferon γ induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells
39. A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal
40. DAP-kinase is a Ca2+/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity
41. DAP kinase links the control of apoptosis to metastasis
42. DAP-kinase participates in TNF-alpha- and Fas-induced apoptosis and its function requires the death domain
43. Inhibition of apoptosis by the retinoblastoma gene product
44. Induction of apoptosis in fibroblasts Myc-myc protein
45. Retinoblastoma protein inhibits IFN-gamma induced apoptosis
46. A restriction point for control of normal animal cell proliferation
47. Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs)
48. Principles of CDK regulation
49. Inhibitors of mammalian G1-cyclin-dependent kinases
50. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins
51. Quantitative studies on viral interference in suspended L cells III. Effect of interfering viruses and interferon on the growth rate of cells
52. Correlation between in vitro and in vivo sensitivity to human leukocyte interferon in patients with multiple myeloma
53. Interferon system defects in malignant T-cells
54. Interferon-induced cell cycle changes in human hematopoietic cell lines and fresh leukemic cells
55. Interferon affects both G1 and S+G2 in cells stimulated from quiescence to growth
56. Alpha interferon suppresses the cyclin D3 and Cdc25A genes, leading to a reversible G0-like arrest
57. Molecular mechansims underlying interferon-α-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complex and activation of pocket proteins
58. Cytokine triggered molecular pathways that control cell cycle arrest
59. p130, p107, and pRb are differentially regulated in proliferating cells and during the cell cycle arrest by alpha-interferon
60. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRb and E2F-4/p130 complexes
61. Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-α in hematopoietic cell lines
62. IFN-alpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells
63. The role of p27Kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells
64. Interferon-alpha induces expression of cyclin-dependent kinase inhibitors p21WAF1 and p27KIP1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK)
65. Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors p19Ink4D and p21Cip1 in mouse macrophages
66. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest
67. Kip1) of cyclin-dependent kinase 4 activation
68. WAF1/CIP1 mediated by STAT1
69. Transcriptionally active STAT1 is required for the antiproliferative effects of both interferon alpha and interferon gamma
70. The JAK-STAT pathway in normal and perturbed hematopoiesis
71. Apoptosis and remodeling of beta cells by paracrine interferon-gamma without insulitis in transgenic mice
72. Interferon gamma induces the expression of p21 waf1 and arrests macrophage cell cycle, preventing induction of apoptosis
73. Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2
74. Isolation and characterization of an interferon-resistant cell line deficient in the induction of (2′,5′) oligoadenylate synthetase activity
75. A dominant negative mutant of 2-5-A-dependent RNaseL suppresses antiproliferative and antiviral effects of interferon
76. IRF-I induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR
77. Retardation of cell proliferation after expression of p202 accompanies an increase in p21 (WAF1/CIP1)
78. Inhibitory effects of interferon on the expression of genes regulated by platelet-derived growth factor
79. Interferon-alpha inhibits proliferation in human T-lymphocytes by abrogation of IL-2 induced changes in cell cycle regulatory proteins
80. Cytokines and JAK-STAT signaling
81. Ras target proteins in eukarotic cells
82. How cells respond to interferons
83. Response to interferon therapy in patients with multiple myeloma correlates with expression of the Bcl-2 oncoprotein
84. The genes of interferons and interferon-related factors: Localization and relationships with chromosome abberations in cancer
85. Primary leukemia cells resistant to IFN-α in vitro are defective in the activation of the DNA-binding factor interferon-stimulated gene factor 3
86. Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3γ
87. Interferon-α resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression
88. Human cancer cell lines express a negative transcriptional regulator of the interferon regulatory factor family of DNA binding proteins
89. Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription
90. A Janus kinase inhibitor, JAB, is an interferon-γ inducible gene and confers resistance to interferons
91. In vivo sensitivity and resistance of CML cells to IFN-α: Correlation with receptor binding and induction of 2′,5′-oligoadenylate synthetase
92. A T-cell acute lymphocytic leukemia patient with two malignant cell populations carrying different deletions of the p16INK4 gene. Response to interferon-α therapy in one of the subclones
93. Are all type I human interferons equivalent?
94. How does interferon exert its cell growth inhibitory effect?